- Home
- ADVM vs TYGO Comparison
ADVM vs TYGO Comparison
Compare ADVM & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- TYGO
- Stock Information
- Founded
- ADVM 2006
- TYGO 2007
- Country
- ADVM United States
- TYGO United States
- Employees
- ADVM N/A
- TYGO N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- TYGO Semiconductors
- Sector
- ADVM Health Care
- TYGO Technology
- Exchange
- ADVM Nasdaq
- TYGO Nasdaq
- Market Cap
- ADVM 59.5M
- TYGO 60.2M
- IPO Year
- ADVM 2014
- TYGO N/A
- Fundamental
- Price
- ADVM $2.22
- TYGO $0.96
- Analyst Decision
- ADVM Strong Buy
- TYGO Strong Buy
- Analyst Count
- ADVM 5
- TYGO 2
- Target Price
- ADVM $26.40
- TYGO $3.75
- AVG Volume (30 Days)
- ADVM 430.7K
- TYGO 21.1K
- Earning Date
- ADVM 05-14-2025
- TYGO 05-06-2025
- Dividend Yield
- ADVM N/A
- TYGO N/A
- EPS Growth
- ADVM N/A
- TYGO N/A
- EPS
- ADVM N/A
- TYGO N/A
- Revenue
- ADVM $1,000,000.00
- TYGO $63,051,000.00
- Revenue This Year
- ADVM N/A
- TYGO $69.44
- Revenue Next Year
- ADVM $42.58
- TYGO $21.75
- P/E Ratio
- ADVM N/A
- TYGO N/A
- Revenue Growth
- ADVM N/A
- TYGO N/A
- 52 Week Low
- ADVM $1.78
- TYGO $0.58
- 52 Week High
- ADVM $10.14
- TYGO $1.85
- Technical
- Relative Strength Index (RSI)
- ADVM 36.90
- TYGO 55.42
- Support Level
- ADVM $2.10
- TYGO $0.92
- Resistance Level
- ADVM $2.33
- TYGO $1.04
- Average True Range (ATR)
- ADVM 0.24
- TYGO 0.07
- MACD
- ADVM 0.03
- TYGO 0.00
- Stochastic Oscillator
- ADVM 32.65
- TYGO 54.29
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.